Navigation Links
Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
Date:10/2/2007

Company enters $800 million market; Initial focus on oncology: most actively researched disease area Researchers to benefit from improved

reagent performance and enhanced productivity

NEWARK, Del., Oct. 2 /PRNewswire-FirstCall/ -- Strategic Diagnostics Inc. (Nasdaq: SDIX) -- today announced the launch of a new internet based catalog of antibody reagents in support of oncology-based research and discovery. These high-quality reagents have all been manufactured utilizing SDI's proprietary Genomic Antibody Technology(TM) and will carry the SEQer(TM) brand. The catalog is available at http://antibodies.sdix.com online.

The catalog has launched with an initial offering of over 200 affinity purified antibody reagents. The Company will supplement this with up to an additional 25 new reagents each week as it strives to become recognized as the fastest-growing site of high quality, leading edge reagents for cancer research.

"Standard antibody production technologies have not changed in more than 20 years," commented Matthew H. Knight, the Company's President and Chief Executive Officer. "The SEQer antibodies in this catalog represent a breakthrough in antibody production and deliver multiple high performance attributes that reduced time, effort and data variation in the laboratory. In addition, the process that produces these reagents is high throughput as evidenced by our initial commitment to add up to 25 new antibody reagents each week. As recognition of SEQer antibody performance grows, we intend to increase this rate."

Mr. Knight continued, "The launch of the SEQer catalog is a direct response to market research highlightin
'/>"/>

SOURCE Strategic Diagnostics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Answerthink and LORENZ Life Sciences Group Announce Strategic Alliance for the SAP Life Science Industry
2. New Advances in Gastric Diagnostics: Smaller is Better
3. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
4. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
7. Immunomedics Reports Initial Clinical Results With Hpam4 For Pancreatic Cancer Therapy
8. Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
9. Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO
10. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
11. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014  RESMED INC. (NYSE: RMD ) ... fiscal year 2015 results on Thursday, January 22, 2015, after ... with ResMed,s results will be issued after 1:00 p.m. US ... discuss operating results and future outlook. The earnings ... Time and the live webcast of the call can be ...
(Date:12/19/2014)... Dec. 18, 2014 Since last month,s FBI ... now known as the leading online black market for ... growth in its offering of drugs and other illegal ... the takedowns did succeed in lowering the numbers of ... of the markets in August. But some new sites ...
(Date:12/19/2014)... LYON, France , Dec. 19, 2014 /PRNewswire/ ... and Adocia (Euronext Paris: FR0011184241 – ADOC) today announced ... insulin, known as BioChaperone Lispro, for treatment in people ... relies on Adocia,s proprietary BioChaperone® technology and is currently ... will develop BioChaperone Lispro with the goal of optimizing ...
Breaking Medicine Technology:ResMed To Announce Second Quarter 2015 Results 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3
... April 25, 2007 /PRNewswire-USNewswire/ -- At least,one-third of ... in childhood or adolescence. However, in children, it ... of other,disorders, notes the May 2007 issue of ... children, usually do not show the,adult cycle of ...
... GmbH (Langenfeld,Germany), a specialty pharmaceutics company announces ... for their proprietary,Sufentanil transdermal patch. , “Today, ... of the second clinical trial for our ... to complete this study in,the first half ...
Cached Medicine Technology:Bipolar Disorder in Children Difficult to Diagnose, Reports the,Harvard Mental Health Letter 2Labtec’s Next Generation Pain Patch Successful in Clinical,Studies 2
(Date:12/19/2014)... 2014 B. E. Smith, the only ... has been retained to lead a national chief ... Franklin, Ind. The top executive search firm in the ... than 900 healthcare executives into organizations. , Johnson ... providing care to the residents of Johnson County and ...
(Date:12/19/2014)... Sarasota, FL (PRWEB) December 19, 2014 ... witnessed someone having difficulty breathing, you probably wished you ... symptom of asthma, COPD, cystic fibrosis, and other breathing ... are prescription medications and avoiding triggers, but other common ... of Asthma Educators conference in San Antonio, TX, 34 ...
(Date:12/19/2014)... 19, 2014 Consilium Staffing, Your ... AMSUS Society for Federal Health Professionals annual meeting ... industry to military and federal healthcare providers. ... Veterans Small Business Engagement (NVSBE) conference last week ... be a vital solution in addressing our nation’s ...
(Date:12/19/2014)... Norton HealthDay Reporter THURSDAY, ... who were exposed to high levels of air pollution late ... a U.S. study suggests. Researchers found that of nearly ... those exposed to the most air pollution during pregnancy were ... autism. And exposure during the third trimester, specifically, showed the ...
(Date:12/17/2014)... December 17, 2014 While countless companies tempt ... not realize the potential dangers of their purchase. Not only ... from a qualified doctor, but patients who buy hCG online ... that there is actually no real hCG present. Illegal internet ... there are no safety standards and may contain unknown fillers ...
Breaking Medicine News(10 mins):Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:Harmonica Techs, Inventors of the Pulmonica®, Unveil New Findings on Complementary Treatments for Asthma 2Health News:Harmonica Techs, Inventors of the Pulmonica®, Unveil New Findings on Complementary Treatments for Asthma 3Health News:Consilium Staffing Increasing Awareness of Locum Tenens through Conference Appearances 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 3
... and concussions among high school athletes found that proper ... concussion. ,In the current study, ... in Philadelphia and co-author Dr. Tracey Covassin of Michigan ... of athletics from Pennsylvania and New Jersey high schools. ...
... Expanding waistlines has been a burgeoning healthcare problem, which has ... obesity rates, is also the increasing// numbers of myths doing ... subject of obesity has been conducted from time to time. ... has painted a dismal scenario of obesity rates by 2010, ...
... Bollywood actor-turned-politician Shatrughan Sinha, now popular talk show host Shekhar Suman ... state - Bihar. ,Suman has proposed to set ... his son Ayush who died of a heart ailment many years ... forward a proposal to set up an ultra modern heart hospital ...
... prevent more sudden deaths than defibrillators in homes ... to US scientists.// ,Researchers at Regions Hospital ... by food supplementation and by electronic devices in ... the population of Olmsted County, Minn., in 2000. ...
... to be wary of the so-called stem cell wonder cures ... properly tested.// ,The health experts had yesterday in ... as a world leader in stem cell research, but cautioned ... and cosmetic skin treatment were yet to be proven, and ...
... Canada can differ according to provinces, says a new study ... ,People on dialysis in Alberta were four times more ... the study conducted over a five-year period found. Saskatchewan, Atlantic ... for kidneys than Ontario. ,"We can say that ...
Cached Medicine News:Health News:Proper Fitting Of Football Helmets Essential To Prevent Concussion 2Health News:Scientists In UK Issue A Caution Over Untested Stem Cell Treatments 2
... optimize the accuracy and precision of Finnpipettes. ... widely recognized by customers throughout the world. ... the years and now covers a full ... filter tips, certified pure tips, stepper tips ...
MBP's extra long 200 L pipet tip will reach the bottom of large tubes and vials, preventing your pipettor from contacting the sample container....
MBP's equivalent to the "Universal Yellow" tip, this 200 L tip utilizes a MicroPoint design for accurate sample handling. 10 L Ref. mark....
The BioCheck LH ELISA is intended for the quantitative determination of luteinizing hormone (LH) in human serum. This assay is useful in the diagnosis and treatment of gonadal dysfunction....
Medicine Products: